STIM
Neuronetics, Inc.
Company overview
- Market capitalization
- $194.68M
- Employees
- 658
- Latest publication
- 2026-09-29
About Neuronetics, Inc.
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20162016-12-31 · USD | Q3 20162016-09-30 · USD | Q2 20162016-06-30 · USD | Q1 20162016-03-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 41,568,000USD | 9,815,000USD | 8,280,000USD | 9,276,000USD | 6,857,000USD |
| Cost Of Revenue | 20,345,000USD | 2,169,000USD | 1,429,000USD | 1,667,000USD | 1,357,000USD |
| Gross Profit | 21,223,000USD | 27,606,000USD | 0USD | 0USD | 0USD |
| Research Development | 1,336,000USD | 2,217,000USD | 1,885,000USD | 2,163,000USD | 1,958,000USD |
| Selling General Administrative | 11,404,000USD | 11,241,000USD | 8,809,000USD | 8,910,000USD | 7,983,000USD |
| Selling And Marketing Expenses | 9,984,000USD | — | — | — | — |
| General And Administrative Expenses | 11,404,000USD | — | — | — | — |
| Total Operating Expenses | 22,724,000USD | 43,565,000USD | 0USD | 0USD | 0USD |
| Operating Income | -1,501,000USD | -9,337,000USD | 0USD | 0USD | 0USD |
| Total Other Income Expense Net | 162,000USD | -1,897,000USD | 0USD | 0USD | 0USD |
| Interest Expense | 2,125,000USD | 555,000USD | 459,000USD | 411,000USD | 410,000USD |
| Net Income | -3,464,000USD | -11,234,000USD | 0USD | 0USD | 0USD |
| Minority Interest | -25,000USD | 0USD | 0USD | 0USD | 0USD |
| Net Income Applicable To Common Shares | -3,439,000USD | -11,234,000USD | 0USD | 0USD | 0USD |
| Unclassified Operating Expenses | — | 30,107,000USD | -10,694,000USD | -11,073,000USD | -9,941,000USD |
| Income Before Tax | — | -11,234,000USD | 0USD | 0USD | 0USD |
| Income Tax Expense | — | 0USD | 0USD | 0USD | 0USD |
| Net Income From Continuing Ops | — | -11,234,000USD | 0USD | 0USD | 0USD |
| Ebit | — | -9,337,000USD | 0USD | 0USD | 0USD |
| Discontinued Operations | — | 0USD | 0USD | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 131,529,000USD | 125,440,000USD | 141,551,000USD | 145,465,000USD | 134,650,000USD | 141,988,000USD | 140,903,000USD | 74,117,000USD |
| Cash And Equivalents | 19,197,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 53,230,000USD | 47,175,000USD | 61,551,000USD | 64,888,000USD | 56,139,000USD | 60,668,000USD | 58,122,000USD | 53,459,000USD |
| Other Current Assets | 3,505,000USD | 13,179,999USD | 5,972,000USD | 6,734,000USD | 6,908,000USD | 8,281,000USD | 9,924,000USD | 7,758,000USD |
| Other Non Current Assets | 2,792,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 109,889,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 28,309,000USD | 28,285,000USD | 30,521,000USD | 28,940,000USD | 27,803,000USD | 24,841,000USD | 31,265,000USD | 16,897,000USD |
| Other Current Liabilities | 425,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 142,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 17,850,000USD | 13,265,000USD | 22,378,000USD | 27,356,000USD | 27,147,000USD | 35,452,000USD | 27,706,000USD | 9,381,000USD |
| Total Equity Including Noncontrolling Interest | 21,640,000USD | — | — | — | — | — | — | — |
| Long Term Debt | 61,519,000USD | 61,297,000USD | 65,807,000USD | 65,671,000USD | 55,539,000USD | 55,341,000USD | 55,151,000USD | 46,002,000USD |
| Deferred Revenue | 1,143,000USD | — | — | — | — | — | — | — |
| Net Receivables | 15,955,000USD | 16,065,999USD | 16,893,000USD | 19,186,000USD | 26,643,000USD | 26,892,000USD | 24,285,000USD | 19,302,000USD |
| Inventory | 5,502,000USD | 4,715,000USD | 4,327,000USD | 4,322,000USD | 4,943,000USD | 4,069,000USD | 4,248,000USD | 4,960,000USD |
| Property Plant Equipment Net | 27,377,000USD | 26,943,000USD | 28,026,000USD | 29,171,000USD | 29,804,000USD | 32,550,000USD | 33,335,000USD | 3,967,000USD |
| Goodwill | 23,622,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 17,420,000USD | 17,785,000USD | 18,149,000USD | 19,113,000USD | 18,878,000USD | 19,242,000USD | 19,606,000USD | — |
| Accounts Payable | 12,419,000USD | 11,433,000USD | 10,739,000USD | 11,573,000USD | 9,725,000USD | 8,482,000USD | 11,077,000USD | 3,295,000USD |
| Short Term Debt | 5,143,000USD | 5,422,000USD | 5,561,000USD | 5,584,000USD | 5,317,000USD | 4,922,000USD | 4,791,000USD | 862,000USD |
| Common Stock | 762,000USD | 696,000USD | 690,000USD | 685,000USD | 661,000USD | 658,000USD | 557,000USD | 303,000USD |
| Retained Earnings | -473,151,000USD | -469,577,000USD | -458,787,000USD | -451,629,000USD | -442,584,000USD | -432,464,000USD | -419,789,000USD | -407,127,000USD |
| Total Liab | — | 108,380,000USD | 115,311,000USD | 114,105,000USD | 103,143,000USD | 102,457,000USD | 109,104,000USD | 64,736,000USD |
| Other Current Liab | — | 10,597,000USD | 13,468,000USD | 11,029,000USD | 11,305,000USD | 10,079,000USD | 13,804,000USD | 10,715,000USD |
| Capital Stock | — | 696,000USD | 690,000USD | 685,000USD | 661,000USD | 658,000USD | 557,000USD | 303,000USD |
| Good Will | — | 23,622,000USD | 23,622,000USD | 22,664,000USD | 19,079,000USD | 18,634,000USD | 18,634,000USD | — |
| Cash | — | 13,214,000USD | 34,134,000USD | 34,471,000USD | 17,469,000USD | 21,224,000USD | 19,459,000USD | 20,867,000USD |
| Cash And Short Term Investments | — | 13,214,000USD | 34,359,000USD | 34,646,000USD | 17,645,000USD | 21,426,000USD | 19,665,000USD | 21,439,000USD |
| Current Deferred Revenue | — | 833,000USD | 753,000USD | 754,000USD | 894,000USD | 785,000USD | 974,000USD | 1,311,000USD |
| Net Debt | — | 72,174,000USD | 56,169,000USD | 56,278,000USD | 63,188,000USD | 61,314,000USD | 63,169,000USD | 27,830,000USD |
| Short Long Term Debt Total | — | 85,388,000USD | 90,303,000USD | 90,749,000USD | 80,657,000USD | 82,538,000USD | 82,628,000USD | 48,697,000USD |
| Long Term Investments | — | 108,000USD | 98,000USD | 94,000USD | 103,000USD | 74,000USD | 86,000USD | 140,000USD |
| Short Term Investments | — | 257,000USD | 225,000USD | 175,000USD | 176,000USD | 202,000USD | 206,000USD | 572,000USD |
| Property Plant Equipment Gross | — | 30,768,000USD | 32,078,000USD | 33,107,000USD | 33,554,000USD | 36,120,000USD | 36,579,000USD | 7,323,000USD |
| Common Stock Shares Outstanding | — | 69,589,000shares | 68,756,000shares | 67,309,000shares | 66,180,000shares | 61,465,000shares | 36,674,000shares | 30,267,000shares |
| Non Current Assets Total | — | 78,265,000USD | 80,000,000USD | 80,577,000USD | 78,511,000USD | 81,320,000USD | 82,781,000USD | 20,658,000USD |
| Non Current Liabilities Total | — | 80,095,000USD | 84,790,000USD | 85,165,000USD | 75,340,000USD | 77,616,000USD | 77,839,000USD | 47,839,000USD |
| Non Current Liabilities Other | — | 71,000USD | — | — | — | — | — | — |
| Non Currrent Assets Other | — | 9,807,000USD | 9,954,000USD | 9,629,000USD | 10,647,000USD | 10,820,000USD | 11,120,000USD | 16,551,000USD |
| Net Working Capital | — | 18,890,000USD | 31,030,000USD | 35,948,000USD | 28,336,000USD | 35,827,000USD | 26,857,000USD | 36,562,000USD |
| Unclassified Non Current Liabilities | — | 18,727,000USD | 18,983,000USD | 19,494,000USD | 19,801,000USD | 22,275,000USD | 22,688,000USD | 1,837,000USD |
| Unclassified Equity | — | 481,450,000USD | 479,785,000USD | 477,615,000USD | 468,409,000USD | 466,600,000USD | 446,381,000USD | 415,902,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 141,551,000USD | 140,903,000USD | 115,831,000USD | 116,884,000USD | 141,223,000USD | 78,657,000USD | 100,168,000USD | 117,022,000USD |
| Intangible Assets | 18,149,000USD | 19,606,000USD | 4,200,000USD | 3,600,000USD | 2,500,000USD | 1,200,000USD | 1,200,000USD | 1,000,000USD |
| Other Current Assets | 5,972,000USD | 9,924,000USD | 7,280,000USD | 4,171,000USD | 4,649,000USD | 3,282,000USD | 2,519,000USD | 1,838,000USD |
| Total Liab | 115,311,000USD | 109,104,000USD | 81,641,000USD | 59,824,000USD | 56,048,000USD | 53,164,000USD | 52,316,000USD | 45,980,000USD |
| Total Stockholder Equity | 22,378,000USD | 27,706,000USD | 34,190,000USD | 57,060,000USD | 85,175,000USD | 25,493,000USD | 47,852,000USD | 71,042,000USD |
| Other Current Liab | 13,468,000USD | 13,804,000USD | 11,777,000USD | 14,178,000USD | 7,569,000USD | 6,593,000USD | 8,331,000USD | 6,942,000USD |
| Common Stock | 690,000USD | 557,000USD | 291,000USD | 273,000USD | 264,000USD | 191,000USD | 186,000USD | 177,000USD |
| Capital Stock | 690,000USD | 557,000USD | 291,000USD | 273,000USD | 264,000USD | 191,000USD | 186,000USD | 177,000USD |
| Retained Earnings | -458,787,000USD | -419,789,000USD | -376,081,000USD | -345,892,000USD | -308,733,000USD | -277,540,000USD | -250,087,000USD | -221,043,000USD |
| Good Will | 23,622,000USD | 18,634,000USD | 0USD | — | — | — | — | — |
| Cash | 34,134,000USD | 19,459,000USD | 59,677,000USD | 70,340,000USD | 94,141,000USD | 48,957,000USD | 75,708,000USD | 104,583,000USD |
| Cash And Short Term Investments | 34,359,000USD | 19,665,000USD | 60,582,000USD | 71,878,000USD | 96,339,000USD | 50,844,000USD | 76,588,000USD | 104,583,000USD |
| Total Current Assets | 61,551,000USD | 58,122,000USD | 93,793,000USD | 98,769,000USD | 115,331,000USD | 65,012,000USD | 88,451,000USD | 114,473,000USD |
| Total Current Liabilities | 30,521,000USD | 31,265,000USD | 19,812,000USD | 33,199,000USD | 15,703,000USD | 13,682,000USD | 27,693,000USD | 13,559,000USD |
| Current Deferred Revenue | 753,000USD | 974,000USD | 1,620,000USD | 1,980,000USD | 2,501,000USD | 2,020,000USD | 2,228,000USD | 2,255,000USD |
| Net Debt | 56,169,000USD | 63,169,000USD | 2,797,000USD | -30,595,000USD | -54,597,000USD | -10,622,000USD | -41,382,000USD | -74,188,000USD |
| Short Term Debt | 5,561,000USD | 4,791,000USD | 845,000USD | 13,949,000USD | 670,000USD | 594,000USD | 11,809,000USD | — |
| Short Long Term Debt Total | 90,303,000USD | 82,628,000USD | 62,474,000USD | 39,745,000USD | 39,544,000USD | 38,335,000USD | 34,326,000USD | 30,395,000USD |
| Long Term Debt | 65,807,000USD | 55,151,000USD | 59,283,000USD | 22,829,000USD | 35,335,000USD | 34,620,000USD | 19,898,000USD | 30,395,000USD |
| Long Term Investments | 98,000USD | 86,000USD | 661,000USD | 362,000USD | 1,697,000USD | 2,331,000USD | 1,730,000USD | — |
| Short Term Investments | 225,000USD | 206,000USD | 905,000USD | 1,538,000USD | 2,198,000USD | 1,887,000USD | 880,000USD | — |
| Net Receivables | 16,893,000USD | 24,285,000USD | 17,838,000USD | 13,821,000USD | 7,780,000USD | 7,166,000USD | 6,569,000USD | 5,620,000USD |
| Inventory | 4,327,000USD | 4,248,000USD | 8,093,000USD | 8,899,000USD | 6,563,000USD | 3,720,000USD | 2,775,000USD | 2,432,000USD |
| Accounts Payable | 10,739,000USD | 11,077,000USD | 4,752,000USD | 2,433,000USD | 4,299,000USD | 3,749,000USD | 4,625,000USD | 3,756,000USD |
| Property Plant Equipment Net | 28,026,000USD | 33,335,000USD | 4,782,000USD | 5,318,000USD | 5,104,000USD | 4,148,000USD | 4,903,000USD | 1,378,000USD |
| Property Plant Equipment Gross | 32,078,000USD | 36,579,000USD | 7,604,000USD | 5,318,000USD | 5,104,000USD | 4,148,000USD | 4,903,000USD | 1,378,000USD |
| Common Stock Shares Outstanding | 65,951,000shares | 31,734,000shares | 28,658,000shares | 26,900,000shares | 25,479,000shares | 18,835,000shares | 18,380,000shares | 8,948,000shares |
| Non Current Assets Total | 80,000,000USD | 82,781,000USD | 22,038,000USD | 18,115,000USD | 25,892,000USD | 13,645,000USD | 11,717,000USD | 2,549,000USD |
| Non Current Liabilities Total | 84,790,000USD | 77,839,000USD | 61,829,000USD | 26,625,000USD | 40,345,000USD | 39,482,000USD | 24,623,000USD | 32,421,000USD |
| Non Currrent Assets Other | 9,954,000USD | 11,120,000USD | 16,595,000USD | 11,575,000USD | 19,091,000USD | 7,166,000USD | 5,084,000USD | 171,000USD |
| Net Working Capital | 31,030,000USD | 26,857,000USD | 73,981,000USD | 65,570,000USD | 99,628,000USD | 51,330,000USD | 60,758,000USD | 100,914,000USD |
| Unclassified Non Current Liabilities | 18,983,000USD | 22,688,000USD | 2,546,000USD | — | -3,224,000USD | -1,741,000USD | -3,779,000USD | -2,026,000USD |
| Unclassified Equity | 479,785,000USD | 446,381,000USD | 409,689,000USD | 402,406,000USD | 393,380,000USD | 302,651,000USD | 299,774,000USD | 293,747,000USD |
| Other Assets | — | — | 1USD | 9,197,000USD | 167,115,000USD | 12,915,000USD | 5,614,000USD | 171,000USD |
| Unclassified Non Current Assets | — | — | -4,200,001USD | -11,937,000USD | -169,615,000USD | -14,115,000USD | -6,814,000USD | — |
| Deferred Long Term Liab | — | — | — | 829,000USD | 6,763,000USD | 1,741,000USD | 3,779,000USD | 2,026,000USD |
| Other Liab | — | — | — | 829,000USD | 1,471,000USD | 1,741,000USD | 2,106,000USD | 2,026,000USD |
| Short Long Term Debt | — | — | — | 13,125,000USD | — | — | 11,250,000USD | — |
| Non Current Liabilities Other | — | — | — | 2,967,000USD | — | 3,121,000USD | 2,619,000USD | — |
| Net Tangible Assets | — | — | — | 57,060,000USD | 85,175,000USD | 25,493,000USD | 46,652,000USD | 70,042,000USD |
| Unclassified Current Liabilities | — | — | — | -12,466,000USD | — | — | -10,550,000USD | — |
| Accumulated Other Comprehensive Income | — | — | — | — | — | 0USD | -2,207,000USD | -2,016,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 1,474,000USD |
| Stock Based Compensation | 2,365,000USD |
| Other Non Cash Items | -539,000USD |
| Change To Account Receivables | 893,000USD |
| Change To Inventory | -1,289,000USD |
| Change To Liabilities | -1,899,000USD |
| Change In Working Capital | 1,091,000USD |
| Operating Cash Flow | -10,429,000USD |
| Capital Expenditures | -614,000USD |
| Unclassified Investing Cash Flow | 25,000USD |
| Investing Cash Flow | -589,000USD |
| Net Debt Issuance | -5,000,000USD |
| Other Financing Activities | -192,000USD |
| Unclassified Financing Cash Flow | 7,023,000USD |
| Financing Cash Flow | 1,831,000USD |
| Change In Cash | -9,187,000USD |
| End Cash Flow | 24,947,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -10,790,000USD | -7,487,000USD | -9,120,000USD | -10,120,000USD | -12,689,000USD | -12,681,000USD | -13,341,000USD | -9,832,000USD |
| Depreciation | 745,000USD | 767,000USD | 886,000USD | 901,000USD | 911,000USD | 446,000USD | 512,000USD | 555,000USD |
| Stock Based Compensation | 1,677,000USD | 2,181,000USD | 1,409,000USD | 1,814,000USD | 1,444,000USD | 1,282,000USD | 1,419,000USD | 1,563,000USD |
| Other Non Cash Items | 2,455,000USD | 858,000USD | 322,000USD | 778,000USD | 194,000USD | 4,563,000USD | 5,494,000USD | 1,008,000USD |
| Change To Account Receivables | 1,008,000USD | 2,157,000USD | 3,863,000USD | 148,000USD | -2,627,000USD | 107,000USD | -630,000USD | -537,000USD |
| Change To Inventory | -432,000USD | -155,000USD | 551,000USD | -966,000USD | 175,000USD | 432,000USD | 874,000USD | 516,000USD |
| Change In Working Capital | -1,831,000USD | 4,589,000USD | 5,718,000USD | 3,123,000USD | -6,853,000USD | -2,206,000USD | 499,000USD | 1,737,000USD |
| Total Cash From Operating Activities | -9,421,000USD | 908,000USD | -785,000USD | -3,504,000USD | -16,993,000USD | -8,596,000USD | -5,417,000USD | -4,969,000USD |
| Capital Expenditures | -197,000USD | -216,000USD | -114,000USD | -252,000USD | -219,000USD | -89,000USD | -386,000USD | -616,000USD |
| Free Cash Flow | -9,618,000USD | 692,000USD | -899,000USD | -3,756,000USD | -17,212,000USD | -8,685,000USD | -5,803,000USD | -5,585,000USD |
| Total Cashflows From Investing Activities | -172,000USD | -215,000USD | -114,000USD | -252,000USD | -219,000USD | -2,376,000USD | 14,000USD | -119,000USD |
| Net Borrowings | -5,000,000USD | -211,000USD | — | — | 0USD | 9,395,000USD | -11,916,000USD | — |
| Total Cash From Financing Activities | -5,577,000USD | -1,029,000USD | 17,901,000USD | 1,000USD | 18,977,000USD | 9,564,000USD | -16,372,000USD | 0USD |
| Issuance Of Capital Stock | 0USD | 0USD | 8,313,000USD | 0USD | 20,700,000USD | — | — | 0USD |
| Change In Cash | -15,170,000USD | -337,000USD | 17,002,000USD | -3,755,000USD | 1,765,000USD | -1,408,000USD | -21,775,000USD | -5,088,000USD |
| Begin Period Cash Flow | 34,134,000USD | 34,471,000USD | 17,469,000USD | 21,224,000USD | 19,459,000USD | 20,867,000USD | 42,642,000USD | 47,730,000USD |
| End Period Cash Flow | 18,964,000USD | 34,134,000USD | 34,471,000USD | 17,469,000USD | 21,224,000USD | 19,459,000USD | 20,867,000USD | 42,642,000USD |
| Other Cashflows From Investing Activities | -25,000USD | 46,000USD | -10,000USD | -12,000USD | — | -2,287,000USD | 400,000USD | 497,000USD |
| Other Cashflows From Financing Activities | -577,000USD | -594,000USD | — | 1,000USD | -1,723,000USD | -436,000USD | -4,456,000USD | -119,000USD |
| Unclassified Operating Cash Flow | -1,677,000USD | — | — | — | — | — | — | — |
| Investments | — | — | -114,000USD | -252,000USD | -219,000USD | -2,376,000USD | 14,000USD | -119,000USD |
| Unclassified Financing Cash Flow | — | — | 9,588,000USD | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | 2,376,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -39,135,000USD | -43,727,000USD | -30,189,000USD | -37,159,000USD | -31,193,000USD | -27,453,000USD | -29,044,000USD | -24,097,000USD |
| Depreciation | 3,465,000USD | 2,073,000USD | 2,006,000USD | 1,648,000USD | 1,060,000USD | 941,000USD | 1,065,000USD | 882,000USD |
| Stock Based Compensation | 6,848,000USD | 5,602,000USD | 7,319,000USD | 8,746,000USD | 7,869,000USD | 4,404,000USD | 3,434,000USD | 1,743,000USD |
| Other Non Cash Items | 1,871,000USD | 11,863,000USD | 2,929,000USD | 1,142,000USD | 918,000USD | 1,993,000USD | 976,000USD | 1,068,000USD |
| Change To Account Receivables | 3,541,000USD | -3,727,000USD | -8,831,000USD | -6,658,000USD | -3,054,000USD | -597,000USD | -950,000USD | -1,353,000USD |
| Change To Inventory | -395,000USD | 3,150,000USD | -1,098,000USD | -2,587,000USD | -3,444,000USD | -945,000USD | -306,000USD | -435,000USD |
| Change In Working Capital | 6,577,000USD | -6,808,000USD | -14,103,000USD | -5,116,000USD | -6,637,000USD | -8,275,000USD | -6,913,000USD | -1,583,000USD |
| Total Cash From Operating Activities | -20,374,000USD | -30,997,000USD | -32,038,000USD | -30,739,000USD | -27,983,000USD | -28,390,000USD | -30,482,000USD | -20,591,000USD |
| Capital Expenditures | -801,000USD | -1,466,000USD | -2,369,000USD | -3,269,000USD | -2,353,000USD | -730,000USD | -813,000USD | -1,011,000USD |
| Free Cash Flow | -21,175,000USD | -32,463,000USD | -34,407,000USD | -34,008,000USD | -30,336,000USD | -29,120,000USD | -31,295,000USD | -21,602,000USD |
| Total Cashflows From Investing Activities | -801,000USD | -2,413,000USD | -1,322,000USD | 6,731,000USD | -9,839,000USD | -730,000USD | -813,000USD | -1,011,000USD |
| Net Borrowings | 9,789,000USD | -2,521,000USD | 23,800,000USD | -91,000USD | 0USD | 1,679,000USD | 2,500,000USD | 2,500,000USD |
| Total Cash From Financing Activities | 35,850,000USD | -6,808,000USD | 22,697,000USD | 207,000USD | 83,006,000USD | 2,369,000USD | 2,420,000USD | 97,038,000USD |
| Sale Purchase Of Stock | -1,731,000USD | 0USD | 0USD | 298,000USD | — | 690,000USD | 2,420,000USD | 97,038,000USD |
| Issuance Of Capital Stock | 29,013,000USD | 0USD | 0USD | 0USD | 80,972,000USD | 0USD | 0USD | 99,998,000USD |
| Change In Cash | 14,675,000USD | -40,218,000USD | -10,663,000USD | -23,801,000USD | 45,184,000USD | -26,751,000USD | -28,875,000USD | 75,436,000USD |
| Begin Period Cash Flow | 19,459,000USD | 59,677,000USD | 70,340,000USD | 94,141,000USD | 48,957,000USD | 75,708,000USD | 104,583,000USD | 29,147,000USD |
| End Period Cash Flow | 34,134,000USD | 19,459,000USD | 59,677,000USD | 70,340,000USD | 94,141,000USD | 48,957,000USD | 75,708,000USD | 104,583,000USD |
| Other Cashflows From Investing Activities | 31,000USD | 1,606,000USD | 1,047,000USD | 10,000,000USD | -7,810,000USD | 1,609,000USD | 2,610,000USD | -7,486,000USD |
| Other Cashflows From Financing Activities | -594,000USD | -4,287,000USD | -1,103,000USD | 207,000USD | 2,034,000USD | -131,000USD | 2,420,000USD | -2,960,000USD |
| Unclassified Financing Cash Flow | 28,386,000USD | — | — | — | — | — | -4,920,000USD | — |
| Investments | — | -2,413,000USD | -1,322,000USD | 10,000,000USD | -9,839,000USD | -730,000USD | -813,000USD | -1,011,000USD |
| Unclassified Investing Cash Flow | — | — | 1,322,000USD | -10,000,000USD | 10,163,000USD | — | -1,797,000USD | 8,497,000USD |
| Change To Liabilities | — | — | — | 4,636,000USD | 491,000USD | -2,818,000USD | 1,848,000USD | 505,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -23,801,000USD | — | -26,751,000USD | -28,875,000USD | 75,436,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | 1,396,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 12,925,000 | USD | 0001104659-26-055322 |
| Q1 2026Quarterly · 2026-03-31 | Product | Services | 21,529,000 | USD | 0001104659-26-055322 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Clinical Services | 21,529,000 | USD | 0001104659-26-055322 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Medical Device | 12,925,000 | USD | 0001104659-26-055322 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 62,180,000 | USD | 0001104659-26-029004 |
| FY 2025Yearly · 2025-12-31 | Product | Services | 86,977,000 | USD | 0001104659-26-029004 |
| FY 2025Yearly · 2025-12-31 | Segment | Clinical Services | 86,977,000 | USD | 0001104659-26-029004 |
| FY 2025Yearly · 2025-12-31 | Segment | Medical Device | 62,180,000 | USD | 0001104659-26-029004 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 13,316,000 | USD | 0001104659-26-055322 |
| Q1 2025Quarterly · 2025-03-31 | Product | Services | 18,659,000 | USD | 0001104659-26-055322 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Clinical Services | 18,659,000 | USD | 0001104659-26-055322 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Medical Device | 13,316,000 | USD | 0001104659-26-055322 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 70,445,000 | USD | 0001104659-26-029004 |
| FY 2024Yearly · 2024-12-31 | Product | Services | 4,445,000 | USD | 0001104659-26-029004 |
| FY 2024Yearly · 2024-12-31 | Segment | Clinical Services | 4,445,000 | USD | 0001104659-26-029004 |
| FY 2024Yearly · 2024-12-31 | Segment | Medical Device | 70,445,000 | USD | 0001104659-26-029004 |
| FY 2018Yearly · 2018-12-31 | Geography | International | 1,299,000 | USD | 0001564590-19-006276 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 51,477,000 | USD | 0001564590-19-006276 |
| Q3 2018Quarterly · 2018-09-30 | Geography | International | 219,000 | USD | 0001564590-18-027435 |
| Q3 2018Quarterly · 2018-09-30 | Geography | United States | 13,518,000 | USD | 0001564590-18-027435 |
| Q2 2018Quarterly · 2018-06-30 | Geography | International | 354,000 | USD | 0001564590-18-021702 |
| Q2 2018Quarterly · 2018-06-30 | Geography | United States | 12,898,000 | USD | 0001564590-18-021702 |
| FY 2017Yearly · 2017-12-31 | Geography | International | 580,000 | USD | 0001564590-19-006276 |
| FY 2017Yearly · 2017-12-31 | Geography | United States | 39,853,000 | USD | 0001564590-19-006276 |
| Q3 2017Quarterly · 2017-09-30 | Geography | International | 93,000 | USD | 0001564590-18-027435 |
| Q3 2017Quarterly · 2017-09-30 | Geography | United States | 10,398,000 | USD | 0001564590-18-027435 |
| Q2 2017Quarterly · 2017-06-30 | Geography | International | 83,000 | USD | 0001564590-18-021702 |
| Q2 2017Quarterly · 2017-06-30 | Geography | United States | 10,225,000 | USD | 0001564590-18-021702 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.